QR-1123
PQ-1123-001
Phase 2 small_molecule active
Quick answer
QR-1123 for Autosomal Dominant Retinitis Pigmentosa is a Phase 2 program (small_molecule) at ProQR Therapeutics N.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ProQR Therapeutics N.V.
- Indication
- Autosomal Dominant Retinitis Pigmentosa
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active